click below
click below
Normal Size Small Size show me how
chapter 19 micro
| Question | Answer |
|---|---|
| Specificity | Each lymphocyte targets one antigen. |
| Memory | Faster response on re-exposure. |
| Clonality | Activated cells clone themselves. |
| Tolerance | Immune system not reacting to self. |
| B cell maturation site | Bone marrow. |
| T cell maturation site | Thymus. |
| Clonal deletion | Destruction of self-reactive lymphocytes. |
| MHC I presents to | CD8 cytotoxic T cells. |
| MHC II presents to | CD4 helper T cells. |
| Cells with MHC II | APCs (macrophages, dendritic cells, B cells). |
| Helper T cell function | Activate B cells and macrophages. |
| Cytotoxic T cell function | Kill infected cells. |
| Regulatory T cell function | Suppress immune responses. |
| Gamma-delta T cells | Fast responders to PAMPs. |
| NK cells | Kill without MHC recognition. |
| NKT cells | Hybrid killer cells that release cytokines quickly. |
| T-dependent activation | Requires CD4 help; strong and makes memory. |
| T-independent activation | No T cell help; weak and no memory. |
| Plasma cell | Antibody-secreting B cell. |
| Memory B cell | Long-term protection. |
| Fab region | Antigen-binding site. |
| Fc region | Determines antibody function. |
| Variable region | Provides antigen specificity. |
| Constant region | Determines isotype class. |
| Hinge region | Provides flexibility. |
| J chain | Allows polymer formation in IgA and IgM. |
| IgM | First antibody produced; pentamer; fixes complement. |
| IgG | Most abundant; crosses placenta; strong opsonin. |
| IgA | Mucosal immunity; found in secretions. |
| IgE | Allergies and parasitic worms. |
| IgD | B cell receptor. |
| Neutralization | Blocks pathogen binding. |
| Opsonization | Tags microbes for phagocytosis. |
| Complement activation | Antibody triggers MAC formation. |
| Primary response | Slow; IgM first; low titer. |
| Secondary response | Fast; IgG dominant; high titer. |
| Natural active immunity | Infection. |
| Natural passive immunity | Breast milk or placenta. |
| Artificial active immunity | Vaccination. |
| Artificial passive immunity | Antiserum or immunoglobulin injection. |
| Purpose of vaccines | Create memory without disease. |
| Adjuvant | Substance that increases vaccine effectiveness. |
| Common adjuvant | Alum (aluminum salts). |
| Live attenuated vaccine | Weak but living microbe. |
| Inactivated vaccine | Killed pathogen. |
| Subunit vaccine | Uses antigenic molecules only. |
| Conjugate vaccine | Polysaccharide linked to protein. |